The full picture: Why we need more demographic data on COVID-19
By now, we're all familiar with the immense strain the COVID-19 pandemic has placed on our health care system, with many medical facilities across the country overburdened by high demand and limited supply as they attempt to deal with an influx of affected patients.
But the crisis has also highlighted other health care challenges, including those related to health equity and the striking disparity in risk and outcomes among racial… 更多The full picture: Why we need more demographic data on COVID-19
By now, we're all familiar with the immense strain the COVID-19 pandemic has placed on our health care system, with many medical facilities across the country overburdened by high demand and limited supply as they attempt to deal with an influx of affected patients.
But the crisis has also highlighted other health care challenges, including those related to health equity and the striking disparity in risk and outcomes among racial and ethnic groups. Current data show, for instance, that African Americans and Latinos are much more likely than others to be infected and die from the disease. Still, demographic information remains sparse, especially for groups like Asians, Native Hawaiians and Pacific Islanders, and American Indians and Alaska Natives.
Uncles, Aunts May Increase Child's Odds for Autism
A child with an uncle or aunt with autism appears to have a more than doubled risk of being diagnosed with an autism spectrum disorder themselves, a new U.S. government-funded study reports.
The global Gastric Cancer Treatment Market is entering a pivotal growth phase. Valued at approximately USD 6.47 billion in 2025, the market is expected to reach nearly USD 14.66 billion by 2033,...
The global Premenstrual Syndrome (PMS) treatment market is projected to increase from USD 1.37 billion in 2022 to USD 1.83 billion by 2031, growing at a CAGR of 4.1%. This growth is fueled by exp...
The global Pruritus Therapeutics Market is projected to grow from USD 8.1 billion in 2023 to USD 15.7 billion by 2031, registering a compound annual growth rate (CAGR) of 8.7% during the forecast...
The Spinal Cord Stimulation Market is expected to exceed USD 7.8 billion by 2032, growing steadily from an estimated USD 3.9 billion in 2024. This upward trajectory is propelled by growing incide...
The frontotemporal disorders treatment market, addressing rare but impactful neurodegenerative diseases, is poised for steady growth. Valued at USD 343.8 million in 2022, it is projected to reach...
shared news
